rs2273761

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP6_Very_StrongBP7BS1BS2

The NM_001134831.2(AHI1):​c.2223T>C​(p.Asp741Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0211 in 1,613,536 control chromosomes in the GnomAD database, including 521 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 63 hom., cov: 32)
Exomes 𝑓: 0.021 ( 458 hom. )

Consequence

AHI1
NM_001134831.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.00500

Publications

10 publications found
Variant links:
Genes affected
AHI1 (HGNC:21575): (Abelson helper integration site 1) This gene is apparently required for both cerebellar and cortical development in humans. This gene mutations cause specific forms of Joubert syndrome-related disorders. Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
AHI1 Gene-Disease associations (from GenCC):
  • Joubert syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Ambry Genetics
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with ocular defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP6
Variant 6-135433070-A-G is Benign according to our data. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135433070-A-G is described in CliVar as Benign. Clinvar id is 128323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.005 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0243 (3703/152296) while in subpopulation EAS AF = 0.0542 (281/5186). AF 95% confidence interval is 0.049. There are 63 homozygotes in GnomAd4. There are 1839 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 63 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AHI1NM_001134831.2 linkc.2223T>C p.Asp741Asp synonymous_variant Exon 16 of 29 ENST00000265602.11 NP_001128303.1 Q8N157-1Q8NER0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AHI1ENST00000265602.11 linkc.2223T>C p.Asp741Asp synonymous_variant Exon 16 of 29 1 NM_001134831.2 ENSP00000265602.6 Q8N157-1

Frequencies

GnomAD3 genomes
AF:
0.0243
AC:
3696
AN:
152178
Hom.:
63
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0362
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0167
Gnomad ASJ
AF:
0.0153
Gnomad EAS
AF:
0.0537
Gnomad SAS
AF:
0.0331
Gnomad FIN
AF:
0.0208
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0172
Gnomad OTH
AF:
0.0258
GnomAD2 exomes
AF:
0.0241
AC:
6006
AN:
248980
AF XY:
0.0248
show subpopulations
Gnomad AFR exome
AF:
0.0386
Gnomad AMR exome
AF:
0.00997
Gnomad ASJ exome
AF:
0.0184
Gnomad EAS exome
AF:
0.0629
Gnomad FIN exome
AF:
0.0184
Gnomad NFE exome
AF:
0.0175
Gnomad OTH exome
AF:
0.0230
GnomAD4 exome
AF:
0.0208
AC:
30418
AN:
1461240
Hom.:
458
Cov.:
31
AF XY:
0.0215
AC XY:
15630
AN XY:
726938
show subpopulations
African (AFR)
AF:
0.0351
AC:
1173
AN:
33454
American (AMR)
AF:
0.0110
AC:
492
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0189
AC:
493
AN:
26126
East Asian (EAS)
AF:
0.0429
AC:
1699
AN:
39618
South Asian (SAS)
AF:
0.0415
AC:
3582
AN:
86246
European-Finnish (FIN)
AF:
0.0192
AC:
1023
AN:
53394
Middle Eastern (MID)
AF:
0.0158
AC:
91
AN:
5764
European-Non Finnish (NFE)
AF:
0.0182
AC:
20255
AN:
1111566
Other (OTH)
AF:
0.0267
AC:
1610
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1574
3149
4723
6298
7872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0243
AC:
3703
AN:
152296
Hom.:
63
Cov.:
32
AF XY:
0.0247
AC XY:
1839
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0362
AC:
1504
AN:
41556
American (AMR)
AF:
0.0167
AC:
255
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0153
AC:
53
AN:
3470
East Asian (EAS)
AF:
0.0542
AC:
281
AN:
5186
South Asian (SAS)
AF:
0.0333
AC:
161
AN:
4830
European-Finnish (FIN)
AF:
0.0208
AC:
221
AN:
10614
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0172
AC:
1172
AN:
68020
Other (OTH)
AF:
0.0251
AC:
53
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
183
366
550
733
916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0202
Hom.:
75
Bravo
AF:
0.0256
Asia WGS
AF:
0.0450
AC:
157
AN:
3476
EpiCase
AF:
0.0186
EpiControl
AF:
0.0186

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Apr 25, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
2.2
DANN
Benign
0.42
PhyloP100
0.0050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2273761; hg19: chr6-135754208; API